FDA Inspection 1273014 — Fagron Compounding Services

Fagron Compounding Services — FEI 3012104093

The FDA completed an inspection of Fagron Compounding Services on August 8, 2025 in Wichita, KS. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
August 8, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Wichita, KS (United States)

Citations

IDCFRDescription
113621 CFR 211.25(c)Inadequate number of personnel
116921 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
121521 CFR 211.67(b)Written procedures not established/followed
145121 CFR 211.113(b)Procedures for sterile drug products
202721 CFR 211.192Investigations of discrepancies, failures
356521 CFR 211.58Buildings not maintained in good state of repair